145 related articles for article (PubMed ID: 23263729)
1. Evaluation of the dose variation for prostate heavy charged particle therapy using four-dimensional computed tomography.
Kumagai M; Okada T; Mori S; Kandatsu S; Tsuji H
J Radiat Res; 2013 Mar; 54(2):357-66. PubMed ID: 23263729
[TBL] [Abstract][Full Text] [Related]
2. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
Bridges D; Kawamura H; Kanai T
PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
[TBL] [Abstract][Full Text] [Related]
3. Four-dimensional treatment planning in layer-stacking boost irradiation for carbon-ion pancreatic therapy.
Mori S; Shinoto M; Yamada S
Radiother Oncol; 2014 May; 111(2):258-63. PubMed ID: 24746568
[TBL] [Abstract][Full Text] [Related]
4. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
[TBL] [Abstract][Full Text] [Related]
5. A serial 4DCT study to quantify range variations in charged particle radiotherapy of thoracic cancers.
Mori S; Dong L; Starkschall G; Mohan R; Chen GT
J Radiat Res; 2014 Mar; 55(2):309-19. PubMed ID: 24142967
[TBL] [Abstract][Full Text] [Related]
6. Technical Note: Predicting dose distribution with replacing stopping power ratio for inter-fractional motion and intra-fractional motion during carbon ion radiotherapy with passive irradiation method for stage I lung cancer.
Kubota Y; Sakai M; Tashiro M; Saitoh JI; Abe T; Ohno T; Nakano T
Med Phys; 2018 Jul; 45(7):3435-3441. PubMed ID: 29757472
[TBL] [Abstract][Full Text] [Related]
7. Carbon-ion scanning lung treatment planning with respiratory-gated phase-controlled rescanning: simulation study using 4-dimensional CT data.
Takahashi W; Mori S; Nakajima M; Yamamoto N; Inaniwa T; Furukawa T; Shirai T; Noda K; Nakagawa K; Kamada T
Radiat Oncol; 2014 Nov; 9():238. PubMed ID: 25384996
[TBL] [Abstract][Full Text] [Related]
8. Variation in patient position and impact on carbon-ion scanning beam distribution during prostate treatment.
Mori S; Inaniwa T; Miki K; Tanimoto K; Tajiri M; Kuroiwa D; Nakao M; Shiraishi Y; Shibayama K; Tsuji H
Br J Radiol; 2015 Jul; 88(1051):20140623. PubMed ID: 25950822
[TBL] [Abstract][Full Text] [Related]
9. Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs.
Mori S; Inaniwa T; Furukawa T; Takahashi W; Nakajima M; Shirai T; Noda K; Yasuda S; Yamamoto N
J Radiat Res; 2014 Sep; 55(5):948-58. PubMed ID: 24835238
[TBL] [Abstract][Full Text] [Related]
10. Four-dimensional lung treatment planning in layer-stacking carbon ion beam treatment: comparison of layer-stacking and conventional ungated/gated irradiation.
Mori S; Kanematsu N; Asakura H; Sharp GC; Kumagai M; Dobashi S; Nakajima M; Yamamoto N; Kandatsu S; Baba M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):597-607. PubMed ID: 20971576
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.
Stenmark MH; Vineberg K; Ten Haken RK; Hamstra DA; Feng M
Med Dosim; 2012; 37(3):240-4. PubMed ID: 22189029
[TBL] [Abstract][Full Text] [Related]
12. Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy.
Hirai R; Mori S; Suyari H; Tsuji H; Ishikawa H
Sci Rep; 2023 May; 13(1):7448. PubMed ID: 37156901
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments.
Ehrbar S; Lang S; Stieb S; Riesterer O; Stark LS; Guckenberger M; Klöck S
Z Med Phys; 2016 Mar; 26(1):45-53. PubMed ID: 26187810
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
15. Determination of internal target volume with Cine-MRI sequence for prostate MRI-Guided radiotherapy.
Wei R; Liang B; Men K; Qin S; Gao L; Lu N; Dai J
Med Phys; 2024 May; 51(5):3566-3577. PubMed ID: 38128057
[TBL] [Abstract][Full Text] [Related]
16. Isotoxic dose escalation in the treatment of lung cancer by means of heterogeneous dose distributions in the presence of respiratory motion.
Baker M; Nielsen M; Hansen O; Jahn JW; Korreman S; Brink C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):849-55. PubMed ID: 21570211
[TBL] [Abstract][Full Text] [Related]
17. The influence of interpatient and intrapatient rectum variation on external beam treatment of prostate cancer.
Yan D; Xu B; Lockman D; Kota K; Brabbins DS; Wong J; Martinez AA
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1111-9. PubMed ID: 11704336
[TBL] [Abstract][Full Text] [Related]
18. A treatment planning strategy for heavy-charged-particle radiotherapy of lung cancer by the use of computed tomography with projection data-based temporal maximum-intensity projection.
Asakura H; Kumagai M; Kanematsu N; Mori S
Radiol Phys Technol; 2010 Jan; 3(1):58-64. PubMed ID: 20821103
[TBL] [Abstract][Full Text] [Related]
19. Practical approaches to four-dimensional heavy-charged-particle lung therapy.
Mori S; Wu Z; Folkert MR; Kumagai M; Dobashi S; Sugane T; Baba M
Radiol Phys Technol; 2010 Jan; 3(1):23-33. PubMed ID: 20821098
[TBL] [Abstract][Full Text] [Related]
20. Determination of optimal PTV margin for patients receiving CBCT-guided prostate IMRT: comparative analysis based on CBCT dose calculation with four different margins.
Gill SK; Reddy K; Campbell N; Chen C; Pearson D
J Appl Clin Med Phys; 2015 Nov; 16(6):252–262. PubMed ID: 26699581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
